These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18504092

  • 1. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA, Hall J, Meyers AL, Gonzales J, Mallinckrodt C.
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [Abstract] [Full Text] [Related]

  • 2. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA, Hall JA, Risser RC, Gonzales JS.
    Pain Pract; 2009 Dec; 9(5):354-62. PubMed ID: 19500272
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell JW.
    Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
    [No Abstract] [Full Text] [Related]

  • 7. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
    Ziegler D, Pritchett YL, Wang F, Desaiah D, Robinson MJ, Hall JA, Chappell AS.
    Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
    Gao Y, Ning G, Jia WP, Zhou ZG, Xu ZR, Liu ZM, Liu C, Ma JH, Li Q, Cheng LL, Wen CY, Zhang SY, Zhang Q, Desaiah D, Skljarevski V.
    Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG, Pritchett YL, Desaiah D, Raskin J.
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Crucitti A, Zhang Q, Nilsson M, Brecht S, Yang CR, Wernicke J.
    Curr Med Res Opin; 2010 Nov; 26(11):2579-88. PubMed ID: 20874076
    [Abstract] [Full Text] [Related]

  • 18. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Nov; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.